New fish oil pill cuts heart risk in study, sends drugmaker’s stock through the roof
Shares continue to surge two days after Amarin touted its study showed dramatic results for heart patients in trial.
Advertisement
Advertisement
Latest from Jade Scipioni
75 banks have now joined JPMorgan to test blockchain payments
The JPMorgan-led project has been growing since launching in 2017.
Sonic being bought by Arby’s parent for $2.3B
America’s Drive-In will now fall under restaurant brand Inspire.
Michael Kors to buy Versace for $2.1B and change its name
Following the acquisition, Kors will change its name to Capri Holdings.
These employers are the most attractive to students
Despite the uptick in startups, many old-school firms made this year’s list.
Weight Watchers changes its name, shifts focus
The company now wants to recast itself as a “technology experience company” known as “WW.”
Amazon is reportedly planting fake packages to catch thieves
A former logistics manager for the company told Business Insider, “It’s meant to be a trap.”
Wells Fargo plans to slash headcount in the next 3 years
The bank foresees 5 percent to 10 percent of its workforce dissolving as part of its ongoing turnaround plan.
Exxon Mobil, Chevron join global coalition to fight climate change
The move is a major reversal for the American oil heavyweights.
Under Armour to slash 400 more jobs in restructuring plan
The cuts equate to about 3 percent of the athletic apparel’s global workforce.